Видео ютуба по тегу Cdk4

Adjuvant CDK4/6 Inhibition: When it Will Become Routine
Adjuvant CDK4/6 Inhibition: When it Will Become Routine
SONIA: optimal CDK4/6 inhibitor position in HR+, HER2- advanced BC
SONIA: optimal CDK4/6 inhibitor position in HR+, HER2- advanced BC
Спросите эксперта: Стефани Графф ответит на ваши вопросы о раке груди на конференции ESMO 2025
Спросите эксперта: Стефани Графф ответит на ваши вопросы о раке груди на конференции ESMO 2025
荷爾蒙陽性乳癌怎麼治？CDK4/6標靶藥物、化療、荷爾蒙治療完整解析
荷爾蒙陽性乳癌怎麼治？CDK4/6標靶藥物、化療、荷爾蒙治療完整解析
DTACs Cyclin D1-CDK4/6 protein complex simulation.
DTACs Cyclin D1-CDK4/6 protein complex simulation.
PENELOPE-B: Exploration of CDK4/6 Inhibition in the Adjuvant Setting
PENELOPE-B: Exploration of CDK4/6 Inhibition in the Adjuvant Setting
Dr Bardia on T-DXd Efficacy By Pace of Prior CDK4/6 Inhibitor Progression in Breast Cancer
Dr Bardia on T-DXd Efficacy By Pace of Prior CDK4/6 Inhibitor Progression in Breast Cancer
Dr. Rugo on Resistance to CDK4/6 Inhibitors in HR+ Breast Cancer
Dr. Rugo on Resistance to CDK4/6 Inhibitors in HR+ Breast Cancer
What is the role of CDK4/6 inhibitors in early breast cancer?
What is the role of CDK4/6 inhibitors in early breast cancer?
Dr Gandhi on Considerations for Continuing CDK4/6 Inhibitors After Progression in HR+ Breast Cancer
Dr Gandhi on Considerations for Continuing CDK4/6 Inhibitors After Progression in HR+ Breast Cancer
CDK 4/6 Inhibitors in Breast Cancer Advanced and Adjuvant Settings
CDK 4/6 Inhibitors in Breast Cancer Advanced and Adjuvant Settings
Первый CDK4/6 ингибитор при раннем РМЖ
Первый CDK4/6 ингибитор при раннем РМЖ
Metastatic HR+/HER2- Breast Cancer Case | CDK4/6 Inhibitors, CNS Progression & Treatment Strategies
Metastatic HR+/HER2- Breast Cancer Case | CDK4/6 Inhibitors, CNS Progression & Treatment Strategies
FirstWord Analyst Notes Ibrance and the next generation of CDK4/6 inhibitors – KOLs speak out
FirstWord Analyst Notes Ibrance and the next generation of CDK4/6 inhibitors – KOLs speak out
"Optimizando los Resultados de los Anti CDK4/6 en el Tratamiento del Cáncer de Mama RH+ HER2-"
CDK4/6 inhibitors and endocrine therapy in elderly female patients with advanced hormone recepto...
CDK4/6 inhibitors and endocrine therapy in elderly female patients with advanced hormone recepto...
Event Topic: Evolving Landscape of CDK4/6i: Breast Cancer | Dr. Manish Singhal
Event Topic: Evolving Landscape of CDK4/6i: Breast Cancer | Dr. Manish Singhal
When to Choose Chemotherapy vs CDK4/6 Inhibitors
When to Choose Chemotherapy vs CDK4/6 Inhibitors
Resistencia a CDK4/6i en cáncer de mama HR+: claves genómicas y terapias futuras
Resistencia a CDK4/6i en cáncer de mama HR+: claves genómicas y terapias futuras
CDK4/6 inhibitors: Closing the express lane in breast cancer
CDK4/6 inhibitors: Closing the express lane in breast cancer
Разработка ингибитора киназ CDK4/6 2-го поколения для терапии пациентов с мГРПРМЖ
Разработка ингибитора киназ CDK4/6 2-го поколения для терапии пациентов с мГРПРМЖ
Ibrance, Kisqali, Verzenio Explained: CDK 4/6 Inhibitors for Breast Cancer?
Ibrance, Kisqali, Verzenio Explained: CDK 4/6 Inhibitors for Breast Cancer?
PUCCINI: early metabolic response predicts survival in patients with mBC receiving CDK4/6 inhibitors
PUCCINI: early metabolic response predicts survival in patients with mBC receiving CDK4/6 inhibitors
HR+ HER2- meme kanserinde kime hangi adjuvan hormonal - cDK4/6 tedavi veririm? - Dr. Taner Korkmaz
HR+ HER2- meme kanserinde kime hangi adjuvan hormonal - cDK4/6 tedavi veririm? - Dr. Taner Korkmaz
CDK4/6 inhibitors: sequencing endocrine therapy for metastatic breast cancer
CDK4/6 inhibitors: sequencing endocrine therapy for metastatic breast cancer